Dongfang Yang
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 11
- Cholinesterase and Neurodegenerative Diseases 9
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 11
- Cholinesterase and Neurodegenerative Diseases 9
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 13
-
- Computational Drug Discovery Methods 4
- Biochemistry top 10%
-
- Hormonal Regulation and Hypertension 5
-
- Pesticide Exposure and Toxicity 4
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Bingfang YanDeshi ShiJian YangChris BlackEdward L. LeCluyseRuitang DengXiulong SongYi-Tzai Chen
- Cited by
- PharmacologyOncology
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Dongfang Yang
52 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 472
- Pharmacology 568
- Oncology 465
- Computational Theory and Mathematics 242
- Biochemistry 74
Countries citing papers authored by Dongfang Yang
This map shows the geographic impact of Dongfang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongfang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongfang Yang more than expected).
Fields of papers citing papers by Dongfang Yang
This network shows the impact of papers produced by Dongfang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongfang Yang. The network helps show where Dongfang Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongfang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 12 | |
| 5 | 2017 | 2 | |
| 6 | 2016 | 38 | |
| 7 | 2016 | 17 | |
| 8 | 2016 | 62 | |
| 9 | 2015 | 33 | |
| 10 | 2012 | 28 | |
| 11 | 2011 | 50 | |
| 12 | 2011 | 37 | |
| 13 | 2010 | 57 | |
| 14 | 2010 | 35 | |
| 15 | 2009 | 50 | |
| 16 | 2006 | 50 | |
| 17 | 2006 | 232 | |
| 18 | 2005 | 11 | |
| 19 | 2004 | 24 | |
| 20 | 1995 | 73 |
About Dongfang Yang
Dongfang Yang is a scholar working on Pharmacology, Oncology and Pharmacology, having authored 53 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (11 papers), Cholinesterase and Neurodegenerative Diseases (9 papers), Hormonal Regulation and Hypertension (5 papers), Pesticide Exposure and Toxicity (4 papers), Computational Drug Discovery Methods (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Pharmacology (472 citations), Pharmacology (568 citations) and Oncology (465 citations). Dongfang Yang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Bingfang Yan, Deshi Shi, Jian Yang, Chris Black, Edward L. LeCluyse, Ruitang Deng, Xiulong Song, Yi-Tzai Chen, Mingxing Xie and Fatemeh Akhlaghi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.